Medical News

RSS

Positive preliminary results from Sinovac EV71 vaccine phase I trial in adults

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the unblinding of the Phase I clinical trial results for the adult population for its proprietary inactivated vaccine against human enterovirus 71, which causes hand, foot, and mouth disease.

10 Mar 2011

FDA approves Matrix NDA for Zidovudine Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.

10 Mar 2011

Coffee consumption may reduce risk of stroke in women

Drinking more than a cup of coffee a day was associated with a 22 percent to 25 percent lower risk of stroke, compared with those who drank less, in a study reported in Stroke: Journal of the American Heart Association.

10 Mar 2011

Cardiome total revenue for fiscal 2010 is $66.1 million

Cardiome Pharma Corp. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Novartis new MS treatment receives Notice of Compliance in Canada

Novartis Pharmaceuticals Canada Inc. announced today that its new MS treatment, Gilenya, has received Notice of Compliance in Canada.

10 Mar 2011

Opinions: Cuts to U.S. foreign aid; sustainable agriculture to feed the world; gender gap in agriculture

The U.S.' "influence and strength depend far more on convincing and enabling the peoples of the world to look to us as a partner for prosperity and security," Truman National Security Project Fellow Michael Lieberman writes in a Huffington Post opinion piece reflecting on House Republican's continuing resolution proposal to reduce foreign aid spending.

10 Mar 2011

Iron deficiency during pregnancy may directly impact infant breathing health

Need a reason to take your iron supplements? Iron deficiency during pregnancy may directly impact infant and childhood breathing health according to a study recently published in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology.

10 Mar 2011

Preliminary phase I trial results show safety of bone marrow stem cells in children with TBI

Stem cells derived from a patient's own bone marrow were safely used in pediatric patients with traumatic brain injury, according to results of a Phase I clinical trial at The University of Texas Health Science Center at Houston.

10 Mar 2011

Scientists develop new model for neurodegenerative disease

A team of scientists at the University of California, San Francisco has developed a new model for how inherited genes contribute to a common but untreatable and incurable neurodegenerative disease.

10 Mar 2011

TGen launches globalCure initiative to fight against pancreatic cancer

In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.

10 Mar 2011

Avinger completes patient enrollment in CONNECT trial to treat CTOs linked with PAD

Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.

10 Mar 2011

FDA approves Covidien's LEU-based Mo-99 medical isotope

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

Medtronic launches VERTEX SELECT CHROMALOY Plus Rods in the U.S.

Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. today announced the U.S. launch of VERTEX SELECT CHROMALOY Plus Rods.

10 Mar 2011

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.

10 Mar 2011

Future Medicine launches Neuropsychiatry

Future Medicine Ltd has today announced the launch of Neuropsychiatry – a new bimonthly title addressing all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world. Neuropsychiatry is published by Future Medicine Ltd (UK, London) renowned for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

10 Mar 2011